EUVIMEDEUVIMED entdecken
Crossref

Discovery of Novel LRPPRC Inhibitors Featuring a Biphenyl-Acylhydrazone Scaffold with Potent Broad-Spectrum Antitumor Activity

Hairu Ren, Jie Liu, Dachi Wang, Junhao Zhang, Jiayan Zhao, Xin Lai, Jian Lu, Wei Zhou, Xuewu Liang, Xiaohong Fang iD, Hong Liu iD

Journal of Medicinal Chemistry · 23.07.2026 · 69 (14) · 17118-17141

DOI: 10.1021/acs.jmedchem.6c00936 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 13.07.2026. Verfasst von Hairu Ren und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, Chi…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Hydrazones, Biphenyl Compounds, Drug Discovery. Die Arbeit nennt 33 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsHydrazonesBiphenyl CompoundsDrug DiscoveryHumansAnimalsCell Line, TumorCell ProliferationMiceStructure-Activity RelationshipDrug Screening Assays, AntitumorMice, Nude

Substanzen

Antineoplastic AgentsHydrazonesBiphenyl Compounds

Autor:innen und Institutionen

  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.
  • School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
  • University of Chinese Academy of Sciences, Beijing 100049, China.
  • Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou 310018, China.

ORCID-Profile: Xiaohong Fang, Hong Liu

Förderung

  • China Postdoctoral Science Foundation

Zitieren

APA

Ren, H., Liu, J., Wang, D., Zhang, J., Zhao, J., Lai, X., Lu, J., Zhou, W., Liang, X., Fang, X., & Liu, H. (2026). Discovery of Novel LRPPRC Inhibitors Featuring a Biphenyl-Acylhydrazone Scaffold with Potent Broad-Spectrum Antitumor Activity. Journal of Medicinal Chemistry, 69(14), 17118-17141. https://doi.org/10.1021/acs.jmedchem.6c00936

Vancouver

Ren H, Liu J, Wang D, Zhang J, Zhao J, Lai X, et al. Discovery of Novel LRPPRC Inhibitors Featuring a Biphenyl-Acylhydrazone Scaffold with Potent Broad-Spectrum Antitumor Activity. Journal of Medicinal Chemistry. 2026;69(14):17118-17141. doi:10.1021/acs.jmedchem.6c00936

BibTeX
@article{Ren2026,
  author = {Ren, Hairu and Liu, Jie and Wang, Dachi and Zhang, Junhao and Zhao, Jiayan and Lai, Xin and Lu, Jian and Zhou, Wei and Liang, Xuewu and Fang, Xiaohong and Liu, Hong},
  title = {Discovery of Novel LRPPRC Inhibitors Featuring a Biphenyl-Acylhydrazone Scaffold with Potent Broad-Spectrum Antitumor Activity},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {14},
  pages = {17118--17141},
  doi = {10.1021/acs.jmedchem.6c00936}
}
Kostenlos starten →